These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32853893)

  • 1. Would it be recommended treating multiple sclerosis relapses with high dose oral instead intravenous steroids during the COVID-19 pandemic? Yes.
    Segamarchi C; Silva B; Saidon P; Garcea O; Alonso R
    Mult Scler Relat Disord; 2020 Nov; 46():102449. PubMed ID: 32853893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.
    Tremlett HL; Luscombe DK; Wiles CM
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):362-5. PubMed ID: 9728950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
    Burton JM; O'Connor PW; Hohol M; Beyene J
    Cochrane Database Syst Rev; 2012 Dec; 12():CD006921. PubMed ID: 23235634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
    Burton JM; O'Connor PW; Hohol M; Beyene J
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006921. PubMed ID: 19588409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.
    Liu S; Liu X; Chen S; Xiao Y; Zhuang W
    PLoS One; 2017; 12(11):e0188644. PubMed ID: 29176905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.
    Barnes D; Hughes RA; Morris RW; Wade-Jones O; Brown P; Britton T; Francis DA; Perkin GD; Rudge P; Swash M; Katifi H; Farmer S; Frankel J
    Lancet; 1997 Mar; 349(9056):902-6. PubMed ID: 9093250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis.
    Reinhardt C; Reul JM; Melms A
    Lancet; 1997 Jun; 349(9066):1697-8. PubMed ID: 9186401
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral administration of methylprednisolone powder for intravenous injection dissolved in water to treat MS and NMOSD relapses during COVID-19 pandemic in a real-world setting.
    Luetic GG; Menichini ML; Fernández Ó
    Mult Scler Relat Disord; 2021 Sep; 54():103148. PubMed ID: 34280680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis.
    De Keyser J; Zwanikken C
    Lancet; 1997 Jun; 349(9066):1696; author reply 1697. PubMed ID: 9186398
    [No Abstract]   [Full Text] [Related]  

  • 10. Corticosteroids in the treatment of multiple sclerosis.
    Myhr KM; Mellgren SI
    Acta Neurol Scand Suppl; 2009; (189):73-80. PubMed ID: 19566504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral or intravenous methylprednisolone for acute relapses of MS?
    Barkhof F; Polman C
    Lancet; 1997 Mar; 349(9056):893-4. PubMed ID: 9093245
    [No Abstract]   [Full Text] [Related]  

  • 12. Corticosteroids for treating optic neuritis.
    Gal RL; Vedula SS; Beck R
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001430. PubMed ID: 26273799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral versus intravenous steroids in multiple sclerosis relapses - a perennial question?
    Chataway J
    Mult Scler; 2014 May; 20(6):643-5. PubMed ID: 24756993
    [No Abstract]   [Full Text] [Related]  

  • 14. Corticosteroids for treating optic neuritis.
    Gal RL; Vedula SS; Beck R
    Cochrane Database Syst Rev; 2012 Apr; 4(4):CD001430. PubMed ID: 22513900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose intravenous corticosteroids in the treatment of multiple sclerosis.
    Ohno R; Hamaguchi K; Sowa K; Tanaka H; Watanabe Y
    Jpn J Med; 1987 May; 26(2):212-6. PubMed ID: 3626160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma.
    Kirkland SW; Cross E; Campbell S; Villa-Roel C; Rowe BH
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012629. PubMed ID: 29859017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Corticosteroids in the treatment of multiple sclerosis and optic neuritis].
    Elovaara I; Pirttilä T
    Duodecim; 2000; 116(15):1547-54. PubMed ID: 12001474
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
    Le Page E; Veillard D; Laplaud DA; Hamonic S; Wardi R; Lebrun C; Zagnoli F; Wiertlewski S; Deburghgraeve V; Coustans M; Edan G; ;
    Lancet; 2015 Sep; 386(9997):974-81. PubMed ID: 26135706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis.
    Tremlett H
    Lancet; 1997 Jun; 349(9066):1696-7. PubMed ID: 9186400
    [No Abstract]   [Full Text] [Related]  

  • 20. A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy.
    Annovazzi P; Tomassini V; Bodini B; Boffa L; Calabrese M; Cocco E; Cordioli C; De Luca G; Frisullo G; Gallo A; Malucchi S; Paolicelli D; Pesci I; Radaelli M; Ragonese P; Roccatagliata L; Tortorella C; Vercellino M; Zipoli V; Gasperini C; Rodegher M; Solaro C
    Neurol Sci; 2013 Feb; 34(2):197-203. PubMed ID: 22407022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.